Long Term Stability Evaluation of Prostacyclin Released from Biomedical Device through Turbiscan Lab Expert

Area of Science:

• Biomedical Engineering
• Pharmaceutical Sciences
• Vascular Medicine

Background:

• Prostacyclins, including Iloprost, are first-line treatments for vascular diseases and inflammation.
• Current intravenous Iloprost administration causes adverse reactions and reduces patient compliance.
• Biomedical devices like elastomeric pumps offer a potential solution for improved Iloprost delivery.

Purpose of the Study:

• To evaluate the long-term stability of Iloprost isotonic solution in elastomeric pumps.
• To assess the suitability of elastomeric pumps for home therapy in peripheral arterial disease patients.
• To investigate the physical-chemical properties and release profile of Iloprost from these devices.

Main Methods:

• Utilized Turbiscan technology to predict long-term stability of Iloprost solutions.
• Measured backscattering and transmission variations of dispersed particulates.
• Evaluated physical-chemical property changes and Iloprost release profiles from the biomedical device.

Main Results:

• The study investigated the long-term stability of Iloprost in solution-loaded elastomeric pumps.
• Turbiscan technology was employed to assess physical-chemical properties and particulate behavior.
• The release profile of Iloprost from the device was also evaluated.

Conclusions:

• Elastomeric pumps show promise for stable, long-term Iloprost delivery in home therapy.
• This approach could mitigate side effects and improve patient compliance for peripheral arterial disease treatment.
• Further research may validate elastomeric pumps as a safe and effective alternative to intravenous infusions.